Evidence map›Paper›PMID 30561167›Full record

ArticleAmerican journal of hematology2019

First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012.

Andrea Bacigalupo, Rosi Oneto, Hubert Schrezenmeier, Britta Hochsmann, Carlo Dufour, Seiji Kojima, Xiaofan Zhu, Xiaojuan Chen, Surapol Issaragrisil, Suporn Chuncharunee and 5 more

Abstract readPublished Erratum
In one paragraph

Article in American journal of hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Andrea BacigalupoIstituto di Ematologia, Universita' Cattolica, Fondazione Universitaria Policlinico Gemelli, Roma, Italy.
Rosi OnetoIstituto di Ematologia, Universita' Cattolica, Fondazione Universitaria Policlinico Gemelli, Roma, Italy.
Hubert SchrezenmeierBlutspende, Ulm University, Ulm, Germany.
Britta HochsmannBlutspende, Ulm University, Ulm, Germany.
Carlo DufourHematology Unity, IstitutoGiannina Gaslini, Genova, Italy.
Seiji KojimaGraduate School of Medicine, Department of Pediatric Hematology, Nagoya University, Nagoya, Japan.
Xiaofan ZhuPediatric Department, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Blood Disease Hospital, Tianjin, China.
Xiaojuan ChenPediatric Department, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Blood Disease Hospital, Tianjin, China.
Surapol IssaragrisilMahidol University, Bangkok, Thailand.
Suporn ChuncharuneeMahidol University, Bangkok, Thailand.
Dae Chul JeongPediatric Department, The Catholic University of Korea, Seoul, Korea.
Sabrina GiammarcoIstituto di Ematologia, Universita' Cattolica, Fondazione Universitaria Policlinico Gemelli, Roma, Italy.
Maria Teresa Van LintDivisione di E di Ematologia, IRCCS AOU San Martino, Genova, Italy.
Yizhou ZhengHematology Department, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Blood Disease Hosoital, Tianjin, China.
Carlos VallejoHospital Universitario de Donostia, San Sebastian, Spain and PETHEMA- Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30561167
PMCPMC6886037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.